Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: terazosin
On March 27, 2019 Hytrin was not listed on the Australian Register of Therapeutic Goods (ARTG).
Healthdirect medicine data is refreshed once a month, see Data sources page. The medicine you searched for may have been added to the ARTG after this date.
Ask your pharmacist, doctor or health professional for advice, or search the ARTG.
Is this medicine available in Australia?
The ARTG is the register of all therapeutic goods that can be lawfully supplied in Australia. Sometimes a special provision is made to make available some medicines that are not listed in response to the needs of particular people or circumstances. To find out more check out the "Access to therapeutic goods not on the ARTG" section on the ARTG page.
Other medicines that contain: terazosin
Alpha blockers have a modest BP lowering effect | Cochrane
The class of drugs called alpha blockers is sometimes used to lower elevated blood pressure. This class includes drugs such as doxazosin (brand name: Cardura), prazosin (Minipress) and terazosin (Hytrin). We asked how much this class of drugs lowers blood pressure and whether there is a difference between individual drugs within the class. The available scientific literature was searched to find all the trials that had assessed this question. We found only 10 trials studying the blood pressure lowering ability of 4 different alpha blockers in 1175 participants. The blood pressure lowering effect was modest. There was an 8-point reduction in the upper number that signifies the systolic pressure and a 5-point reduction in the lower number that signifies the diastolic pressure. No alpha blocker drug appears to be any better or worse than others in terms of blood pressure lowering ability. Due to incomplete reporting of the number of participants who dropped out of the trials due to adverse drug reactions, as well as the short duration of these trials, this review could not provide an estimate of the harms associated with this class of drugs.
Read more on Cochrane (Australasian Centre) website